{
  "denotations": [
    {
      "id": "T1",
      "obj": "Disease",
      "span": {
        "begin": 30,
        "end": 57
      }
    },
    {
      "id": "T2",
      "obj": "Disease",
      "span": {
        "begin": 115,
        "end": 121
      }
    },
    {
      "id": "T3",
      "obj": "Chemical",
      "span": {
        "begin": 136,
        "end": 140
      }
    },
    {
      "id": "T5",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 172,
        "end": 175
      }
    },
    {
      "id": "T7",
      "obj": "Chemical",
      "span": {
        "begin": 136,
        "end": 169
      }
    },
    {
      "id": "T8",
      "obj": "Disease",
      "span": {
        "begin": 81,
        "end": 99
      }
    }
  ],
  "sourcedb": "PubMed",
  "sourceid": "17949449_9",
  "text": "CONCLUSION : In patients with Dukes ' C colorectal cancer who underwent curative surgical resection of the primary tumour , followed by 5-FU -based adjuvant chemotherapy , p53 mutation status as assessed by gene sequencing is a significant predictor of overall and metastasis-free survival ."
}
